227 related articles for article (PubMed ID: 10815736)
1. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon.
Kuaban C; Bercion R; Jifon G; Cunin P; Blackett KN
Int J Tuberc Lung Dis; 2000 May; 4(5):427-32. PubMed ID: 10815736
[TBL] [Abstract][Full Text] [Related]
2. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995.
Bercion R; Kuaban C
Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073
[TBL] [Abstract][Full Text] [Related]
3. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Bercion R; Kuaban C
Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
[TBL] [Abstract][Full Text] [Related]
4. Anti-tuberculosis drug resistance in the West Province of Cameroon.
Kuaban C; Bercion R; Noeske J; Cunin P; Nkamsse P; Ngo Niobe S
Int J Tuberc Lung Dis; 2000 Apr; 4(4):356-60. PubMed ID: 10777086
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
7. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis complex strains and drug susceptibility in a cattle-rearing region of Cameroon.
Kuaban C; Um Boock A; Noeske J; Bekang F; Eyangoh S
Int J Tuberc Lung Dis; 2014 Jan; 18(1):34-8. PubMed ID: 24365549
[TBL] [Abstract][Full Text] [Related]
9. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
Al-Rubaish AM; Madania AA; Al-Muhanna FA
Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
[TBL] [Abstract][Full Text] [Related]
11. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
12. Anti-tuberculosis drug resistance in Portugal.
Antunes ML; Aleixo-Dias J; Antunes AF; Pereira MF; Raymundo E; Rodrigues MF
Int J Tuberc Lung Dis; 2000 Mar; 4(3):223-31. PubMed ID: 10751067
[TBL] [Abstract][Full Text] [Related]
13. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
15. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
16. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
17. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
18. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
[TBL] [Abstract][Full Text] [Related]
19. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
Crudu V; Arnadottir T; Laticevschi D
Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
